CynosBio

Developer of regenerative medicine technology designed for knee osteoarthritis. The company develops human autologous oral mucosa-derived epithelial cell sheets using human amniotic membrane substrate...

Healthcare

Tokyo, Japan

Founded 2015

Website

Valuation

$26.9M

Market implied

Share Price

N/A

Total Raised

$12.8M

Last Round

N/A

Investors

+11 other investors

View all 11 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock CynosBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required